#pharmaceuticals — Public Fediverse posts

Beyond the scale: Men turn to cosmetic clinics to complete weight-loss transformation https://www.japantimes.co.jp/news/2026/09/07/world/science-health/men-cosmetic-clinics-weight-loss/?utm_medium=Social&utm_source=mastodon #worldnews #sciencehealth #glp1 #health #pharmaceuticals #plasticsurgery

BS PHARM KOREA Strengthens INHILO+ Market Development Through Distribution and Clinical Collaboration

INHILO+ represents our approach to professional aesthetic product development through differentiated formulation concepts, clinical evaluation, and collaboration with…
#EuropeSays #Korea #KR #Biotechnology #BSPHARMKOREA #CosmeticsandPersonalCare #MedicalPharmaceuticals #Pharmaceuticals
https://www.europesays.com/korea/144885/

https://www.europesays.com/ch/126504/ Novartis India eyes therapy-aligned acquisition, Tier 2-3 market push | Company News #arthritis #CardiovascularDisease #ChronicAndLifestyleLinkedDiseases #diabetes #GreaterInsurancePenetration #HealthcareInfrastructure #India #ManagingDirectorAndChiefExecutiveOfficer #Myfortic #NeurologicalDisorders #Neuroscience #Novartis #NOVARTISINDIALTD #Pain #PainManagement #Pharmaceuticals(NEC) #sandoz #Simulect #VikasGupta

https://www.europesays.com/ch/126132/ Novartis’ experimental cardiovascular drug fails a pivotal study #biotechnology #cardiology #Novartis #Pharmaceuticals #STAT+

https://www.europesays.com/ch/126102/ Roche, Pfizer, Bristol Meyers Squibb, eGenesis: Pharmalittle #biotechnology #DrugDevelopment #Pharmaceuticals #pharmalittle #Roche #STAT+

DHL partners local life-sciences incubator to provide cold chain logistics for biotech startups

The company will support the transportation of biological and healthcare shipments [SINGAPORE] DHL Express Singapore has entered into…
#Germany #DE #Europe #EU #Europa #DHL #Biotech #DeutschePost #Pharmaceuticals #Singaporepharmaceuticals
https://www.europesays.com/germany/84886/

https://www.europesays.com/ch/125546/ Switzerland’s Roche joins race to make coronavirus antibody tests #AbbottLaboratories #BectonDickinsonAndCo #BiotechAndPharmaceuticals #biotechnology #BusinessNews #Coronavirus:Prevention #DiaSorinSpA #HealthCareIndustry #Pharmaceuticals #Roche #RocheHoldingAG #Switzerland

https://www.europesays.com/ch/124651/ Roche weight loss drug shows promising results in early trial #BiotechAndPharmaceuticals #biotechnology #BreakingNews #business #BusinessNews #CarmotTherapeuticsInc #EliLillyAndCo #HealthCareIndustry #NovoNordiskA/S #Pharmaceuticals #Roche #RocheHoldingAG

https://www.europesays.com/ch/124100/ Novo Nordisk, Eli Lilly shares slide on Roche’s obesity drug trial #BiotechAndPharmaceuticals #BreakingNews:Markets #business #BusinessNews #EliLillyAndCo #HealthCareIndustry #Markets #NovoNordiskA/S #Pharmaceuticals #Roche #RocheHoldingAG #ZealandPharmaA/S

The health ministry plans not to impose consumption tax on additional out-of-pocket costs for prescription drugs with ingredients and effects similar to those of over-the-counter medicines, sources said Monday. https://www.japantimes.co.jp/news/2026/08/31/japan/otc-drugs-tax-exemption/?utm_medium=Social&utm_source=mastodon #japan #consumptiontax #taxes #medicine #pharmaceuticals #health #mhlw #drugs #drugstores

GLP-1 drug prescribed to woman with eating disorder via telehealth
By Lauren Roberts and Genelle Weule

The ABC has learned of a young woman with anorexia nervosa who was prescribed an Ozempic-like drug through a telehealth clinic. Experts say the incident highlights the need for more oversight.

https://www.abc.net.au/news/health/2026-08-31/telehealth-ozempic-wegovy-eating-disorder/107016932

#EatingDisorders #PharmaceuticalIndustry #Pharmaceuticals #LaurenRoberts #GenelleWeule

New testing of black-market peptides reveals high-dose risk
By Rachel Carbonell, Caitlyn Gribbin, and Andi Yu

A chemical testing lab begins testing unapproved peptides as demand for the products booms on social media.

https://www.abc.net.au/news/2026-08-28/black-market-peptides-dangerous-doses/107059092

#Pharmaceuticals #PharmaceuticalIndustry #ScientificResearch #RachelCarbonell #CaitlynGribbin #AndiYu

#drugoverdoses #alcohol #pharmaceuticals #pharmaceuticalindustry #culture #americanculture #warondrugs #legaldrugpushers #ceos

Former AstraZeneca associate legal director joins Han Kun | China

Wang Rongxia Han Kun Law Offices has appointed Wang Rongxia as patent counsel in Beijing, further strengthening the…
#EuropeSays #Britain #Europe #EU #AstraZeneca #Beijing #Biotechnology #Chemicals #China #HanKunLawOffices #Intellectualproperty #Patent #PatentLaw #Patentlitigation #Pharmaceuticals #WangRongxia
https://www.europesays.com/britain/87783/

https://www.europesays.com/britain/87783/ Former AstraZeneca associate legal director joins Han Kun | China #AstraZeneca #Beijing #Biotechnology #Chemicals #China #HanKunLawOffices #IntellectualProperty #Patent #PatentLaw #PatentLitigation #Pharmaceuticals #WangRongxia

Map reveals Australia's 'pharmacy deserts' are not all in the bush
By Lauren Roberts

Australia's "pharmacy deserts" have been mapped for the first time, revealing remote NT communities and outer-city Melbourne have fewer pharmacies per person than some other parts of the country.

https://www.abc.net.au/news/health/2026-07-22/pharmacy-deserts-in-australia-mapped/106883376

#Health #Pharmaceuticals #PharmaceuticalIndustry #PublicHealth #LaurenRoberts

The Guardian: Kalshi to offer betting on drug trial results and FDA regulatory decisions. “Kalshi is expanding its wagers to include bets on drug trial results, an expansion into new predictions territory as platforms continue to rapidly gain popularity and offer opportunities to bet on virtually anything.”

MS patients given PBS lifeline amid drug pricing dispute
By Clare Armstrong

Health Minister Mark Butler has accepted independent advice for a rapid review of MS drugs to ensure they remain available on the PBS.

https://www.abc.net.au/news/2026-07-16/ms-patients-given-pbs-lifeline/106925112

#MultipleSclerosis #Pharmaceuticals #Health #FederalGovernment #PharmaceuticalIndustry #ClareArmstrong

Australians paying 'unjustified' fees to pharmacies, report says
By Paige Cockburn

Taxpayers are missing out on cheaper medicines due to backroom deals by one of Australia's most powerful lobby groups, according to a new report.

https://www.abc.net.au/news/2026-07-12/pharmacy-guild-lobbying-means-patients-get-bad-deal-report/106901974

#PharmaceuticalIndustry #Pharmaceuticals #Health #FederalGovernment #PaigeCockburn

Critical drugs could be pulled from PBS amid pricing stoush
By Clare Armstrong and Stephanie Dalzell

The latest PBS stoush with drugmakers means thousands of people with MS are at risk of being forced to pay $33,000 a year for lifesaving medication.

https://www.abc.net.au/news/2026-07-08/ms-drugs-could-be-pulled-from-pbs-pricing-stoush/106890154

#FederalGovernment #GovernmentandPolitics #FederalParliament #Pharmaceuticals #MultipleSclerosis #PharmaceuticalIndustry #Health #ClareArmstrong #StephanieDalzell

Reality of Trump’s drug pricing to set in over next 18 months

Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #AstraZenecaPLC #BreakingNews:Politics #Business #businessnews #donaldtrump #GileadSciencesInc #Health #Healthcareindustry #NovartisAG #Pharmaceuticals #politics #RocheHoldingAG #SanofiSA
https://www.newsbeep.com/us/611174/

Top clinical research companies in India: IQVIA, Parexel, Syneos & more!
Land your dream role—get insights with BioResire.
Join students: https://whatsapp.com/channel/0029Vb5u2Tp77qVTb1D7bu3r

#ClinicalResearch #BioResire #IQVIA #ParexelIndia #SyneosHealth #IndiaCRO #ClinicalTrials #BiotechJobs #LifeSciences #PharmaCareers #IndiaPharma #ClinicalResearchIndia #CROJobs #Bioinformatics #ResearchJobs #BioResireStudents #HealthcareJobs #Pharmaceuticals #JobOpportunities #WhatsAppStudents

African scientists push for homegrown pharma innovation
#Health #GlobalHealth #Africa #HealthInnovation #Pharmaceuticals #MedicalResearch #SciencePolicy #AfricanScientists #HealthEquity #RAndD #VaccineEquity #AidDependency #LocalInnovation #GlobalSouth
https://the-14.com/african-scientists-push-for-homegrown-pharma-innovation/

African scientists push for homegrown pharma innovation
#Health #GlobalHealth #Africa #HealthInnovation #Pharmaceuticals #MedicalResearch #SciencePolicy #AfricanScientists #HealthEquity #RAndD #VaccineEquity #AidDependency #LocalInnovation #GlobalSouth
https://the-14.com/african-scientists-push-for-homegrown-pharma-innovation/

African scientists push for homegrown pharma innovation
#Health #GlobalHealth #Africa #HealthInnovation #Pharmaceuticals #MedicalResearch #SciencePolicy #AfricanScientists #HealthEquity #RAndD #VaccineEquity #AidDependency #LocalInnovation #GlobalSouth
https://the-14.com/african-scientists-push-for-homegrown-pharma-innovation/

African scientists push for homegrown pharma innovation
#Health #GlobalHealth #Africa #HealthInnovation #Pharmaceuticals #MedicalResearch #SciencePolicy #AfricanScientists #HealthEquity #RAndD #VaccineEquity #AidDependency #LocalInnovation #GlobalSouth
https://the-14.com/african-scientists-push-for-homegrown-pharma-innovation/

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to approaching the brain-wasting disease as a system of complex pathways. https://www.japantimes.co.jp/news/2025/12/12/world/science-health/alzheimers-trials-shift-approach/?utm_medium=Social&utm_source=mastodon #worldnews #sciencehealth #aging #dementia #alzheimer039s #pharmaceuticals #medicine #eisai #novonordisk

Donald Trump’s Big Pharma Showdown Ends with a Whimper

https://web.brid.gy/r/https://www.newyorker.com/news/the-financial-page/donald-trumps-big-pharma-showdown-ends-with-a-whimper

A health ministry panel approved a plan to cut the price of Lecanemab, an Alzheimer's drug that Japanese drugmaker Eisai and U.S. industry peer Biogen codeveloped, by 15% in Japan starting Nov. 1. https://www.japantimes.co.jp/news/2025/08/07/japan/science-health/japan-alzheimer-drug-price-cut/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #alzheimer039s #medicine #pharmaceuticals #eisai #health

Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings

Exclusive: a Nature analysis signals the beginnings of a #US #science #BrainDrain. A trawl of job views and application data suggests #jobseekers are looking abroad as the #Trump administration’s cuts to science take hold.
https://www.nature.com/articles/d41586-025-01216-7 #science #sciences #research #researchers #education #healthcare #medicine #pharmaceuticals

I hope I don't think of this when I hear this song in the future. I truly do hope I don't think of this, next time. What have I done? No where to run; no pee to run. ain't no fun.

#humor #penishumor

It's lit-to-pop but now
your pee gonna Stop!

One come a day
No water will run
Nobody could stand the wait
for pee to come

( "You old!!..." )

One come a day
No water will run
Nobody could stand the wait
for pee to come

erection for some
help my pee to come.
help pee to come.
my pee will run.
it will runnnnnnn......
[ #DaveNavarro pick-slide-shit ]
"C'mon! Go!"
( ??? )

Stop!

https://youtu.be/beWnAmN1y3o?si=K0ssm_bBNwite3Xc

#ProstateCancer #perryfarrell #Prostate #perry_farrell #enlarged #parody #parodyromance #bromance #PsychoGeography #TwilightZone #perfectsong #pharmaceuticals

Teams of researchers from Niigata University and the University of Tokyo have begun an international clinical trial to check the effectiveness and safety of a treatment for familial Alzheimer's disease. https://www.japantimes.co.jp/news/2024/03/15/japan/science-health/familial-alzheimers-treatment-trial/ #japan #sciencehealth #alzheimer039s #eisai #pharmaceuticals

Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi to 1,500 people in China later this year, but expects growth to accelerate significantly in 2025 as diagnosis methods change, according to a company spokesperson. https://www.japantimes.co.jp/business/2024/02/05/companies/eisai-alzheimers-drug-china/?utm_content=buffer2498b&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #business #companies #eisai #pharmaceuticals #alzheimer039s #china

New Alzheimer's drug lecanemab will cost around ¥2.98 million per year in Japan, but will be largely covered by public health insurance that will limit the burden for patients to between 10% and 30% of that cost, subject to a cap, a health ministry body has said. https://www.japantimes.co.jp/news/2023/12/13/japan/eisai-biogen-alzheimers-drug-price/?utm_content=buffer4dd52&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #alzheimer039s #drugs #eisai #biogen #pharmaceuticals

A health ministry panel reviewing the new Alzheimer’s drug lecanemab greenlighted its approval in Japan on Monday. https://www.japantimes.co.jp/news/2023/08/21/japan/science-health/lecanemab-alzheimers-drug-approval/?utm_content=buffer356e4&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #lecanemab #eisai #alzheimer039s #pharmaceuticals #health

New hope for cancer cure as a pill ‘annihilates all solid tumors’ thanks to a little girl

#California #cancer #CityofHope #Duarte #health #HealthNews #healthcare #HumanInterest #medicalbreakthroughs #medicalcare #Medicine #pharmaceuticals
https://theaegisalliance.com/2023/08/10/new-hope-for-cancer-cure-as-a-pill-annihilates-all-solid-tumors-thanks-to-a-little-girl/?feed_id=13138&_unique_id=64d5af3c4a203

Drug giant Eisai's global Alzheimer drug program officer Ivan Cheung will be replaced by the son of the firm’s CEO, after a tenure that saw Cheung lead the push for U.S. approval of breakthrough medicine Leqembi. https://www.japantimes.co.jp/news/2023/07/11/business/corporate-business/eisai-alzheimers-leqembi-ivan-cheung-ceo-son-keisuke-naito/?utm_content=bufferfeb39&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #news #corporate #pharmaceuticals #alzheimers #eisai #keisukenaito

Expectations for the Alzheimer's treatment lecanemab are rising in Japan and it could be approved as early as fall, but even then there would be several barriers to its widespread adoption. https://www.japantimes.co.jp/news/2023/07/04/national/science-health/lecanemab-japan-approval-expectations/?utm_content=bufferb2b8f&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #news #japan #aging #elderly #pharmaceuticals #dementia #alzheimers #eisai #medicine